208
At the meeting, Zhang said China is determined to promote high-level openness and will continue to support the development of foreign companies, including Novo Nordisk in China.
China considers protecting people’s health a strategic priority and actively promotes the development of biomedicine, Zhang said, praising the strong foundation for cooperation in the fields of biomedical innovation, research and development.
Welcoming China’s economic and social development achievements, Jorgensen expressed full confidence in the company’s development prospects in China. He said that Novo Nordisk will continue to explore the Chinese market to achieve win-win results.
*With Xinhua
